This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          
HOPE LOGO

Dermatology

Ceramide routine significantly reduces local adverse effects from topical acne therapy
Ceramide routine significantly reduces local adverse effects from topical acne therapy
Read more
Review suggests biologics safe for pregnant women with psoriasis
Review suggests biologics safe for pregnant women with psoriasis
Read more
Is topical roflumilast the rising star of dermatological treatments?
Is topical roflumilast the rising star of dermatological treatments?
Read more
Study finds no increased risk of skin cancer from UVB phototherapy for atopic eczema
Study finds no increased risk of skin cancer from UVB phototherapy for atopic eczema
Read more
Faster diagnosis and treatment for skin cancer as NHS plans accelerated rollout of teledermatology
Faster diagnosis and treatment for skin cancer as NHS plans accelerated rollout of teledermatology
Read more
Spironolactone safe and effective for treating acne in women, research confirms
Spironolactone safe and effective for treating acne in women, research confirms
Read more
RCT finds tralokinumab effective in adolescents with atopic eczema
RCT finds tralokinumab effective in adolescents with atopic eczema
Read more
Bimekizumab shows promise in hidradenitis suppurativa
Bimekizumab shows promise in hidradenitis suppurativa
Read more
Enhanced vs reactive treatment of atopic eczema reduces hen egg allergy
Enhanced vs reactive treatment of atopic eczema reduces hen egg allergy
Read more
RCT finds oral vitamin D fails to improve disease severity in psoriasis
RCT finds oral vitamin D fails to improve disease severity in psoriasis
Read more
Lebrikizumab monotherapy effective in moderate to severe atopic eczema
Lebrikizumab monotherapy effective in moderate to severe atopic eczema
Read more
Dupilumab treatment improves spontaneous chronic urticaria activity and quality of life
Dupilumab treatment improves spontaneous chronic urticaria activity and quality of life
Read more
Adherence to NICE criteria for biologic treatment in atopic dermatitis
Adherence to NICE criteria for biologic treatment in atopic dermatitis
Read more
Dupixent approved for severe atopic dermatitis in children from 6 months
Dupixent approved for severe atopic dermatitis in children from 6 months
Read more
Lebrikizumab and topical steroids effective in moderate to severe atopic eczema
Lebrikizumab and topical steroids effective in moderate to severe atopic eczema
Read more
Early emollient use among high-risk infants prevents atopic eczema
Early emollient use among high-risk infants prevents atopic eczema
Read more
Dupixent recommended for EU approval to treat moderate to severe prurigo nodularis
Dupixent recommended for EU approval to treat moderate to severe prurigo nodularis
Read more

Popular articles

Does cancer screening actually reduce all-cause mortality?
Stress and high workload confirmed as main reasons staff leave NHS
Ruxolitinib approved by NICE for treatment of polycythaemia vera





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×